Corvus Pharmaceuticals, Inc. (CRVS)
Largest Insider Buys in Sector
CRVS Stock Price History Chart
CRVS Stock Performance
About Corvus Pharmaceuticals, Inc.
Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, which is in Phase Ib/II clinical trial for non-small cell lung cancer and head and neck cancers. The company also develops CPI-818, a covalent inhibitor of ITK, which is in Phase I/Ib clinical trial to treat patients with various malignant T-cell lymphomas, as well as designed to inhibit the proliferation of certain malignant T-cells; and Ciforadenant (CPI-444), an oral, small molecule antagonist of the A2A receptor that is in Phase II clinical trial for patients with either advanced or refractory renal cell cancer. Its preclinical stage products include CPI-182, an antibody designed to block inflammation and myeloid suppression; and CPI-935, an adenosine A2B receptor antagonist to prevent fibrosis. Corvus Pharmaceuticals, Inc. has a strategic collaboration with Angel Pharmaceuticals for the development its pipeline of targeted investigational medicines. The company was incorporated in 2014 and is based in Burlingame, California.
Insider Activity of Corvus Pharmaceuticals, Inc.
Over the last 12 months, insiders at Corvus Pharmaceuticals, Inc. have bought $1.03M and sold $0 worth of Corvus Pharmaceuticals, Inc. stock.
On average, over the past 5 years, insiders at Corvus Pharmaceuticals, Inc. have bought $3.33M and sold $17.61M worth of stock each year.
Highest buying activity among insiders over the last 12 months: MILLER RICHARD A MD (President and CEO) — $1,000,000. Jones William Benton (See Remarks) — $34,624.
The last purchase of 577,634 shares for transaction amount of $1,000,000 was made by MILLER RICHARD A MD (President and CEO) on 2024‑05‑06.
List of Insider Buy and Sell Transactions, Corvus Pharmaceuticals, Inc.
| 2024-05-06 | MILLER RICHARD A MD | President and CEO | 577,634 1.0676% | $1.73 | $1,000,000 | +9.95% | ||
| 2024-05-06 | Jones William Benton | See Remarks | 20,000 0.037% | $1.73 | $34,624 | +9.95% | ||
| 2023-05-15 | Grais Linda | director | 10,000 0.0202% | $2.45 | $24,500 | -23.08% | ||
| 2022-12-20 | Jones William Benton | See Remarks | 20,000 0.0435% | $0.79 | $15,800 | +85.90% | ||
| 2022-12-14 | MILLER RICHARD A MD | President and CEO | 10,000 0.021% | $0.78 | $7,812 | +78.13% | ||
| 2022-12-14 | LEA LEIV | Chief Financial Officer | 4,000 0.009% | $0.84 | $3,364 | +78.13% | ||
| 2022-12-13 | MILLER RICHARD A MD | President and CEO | 50,000 0.1031% | $0.74 | $37,015 | +84.18% | ||
| 2022-12-13 | LEA LEIV | Chief Financial Officer | 30,000 0.0621% | $0.74 | $22,275 | +84.18% | ||
| 2022-06-24 | MILLER RICHARD A MD | President and CEO | 5,000 0.0123% | $1.00 | $4,985 | +4.60% | ||
| 2022-06-02 | MILLER RICHARD A MD | President and CEO | 890 0.002% | $1.01 | $899 | -7.89% | ||
| 2022-03-31 | MILLER RICHARD A MD | President and CEO | 15,000 0.0321% | $1.64 | $24,534 | -44.51% | ||
| 2022-03-16 | LEA LEIV | Chief Financial Officer | 13,878 0.0307% | $1.65 | $22,899 | -42.38% | ||
| 2022-03-15 | MILLER RICHARD A MD | President and CEO | 5,000 0.0117% | $1.59 | $7,950 | -36.44% | ||
| 2021-10-01 | Sale | EcoR1 Capital, LLC | 10 percent owner | 2M 4.4342% | $4.96 | $9.93M | -67.36% | |
| 2021-09-30 | Sale | EcoR1 Capital, LLC | 10 percent owner | 3M 6.7156% | $5.04 | $15.13M | -67.46% | |
| 2021-09-20 | Sale | Thompson Peter A. | 1.11M 2.4922% | $6.09 | $6.76M | -73.58% | ||
| 2021-09-20 | Sale | ORBIMED ADVISORS LLC | 1.11M 2.4922% | $6.09 | $6.76M | -73.58% | ||
| 2021-08-20 | MILLER RICHARD A MD | President and CEO | 10,000 0.0229% | $1.93 | $19,254 | -5.76% | ||
| 2021-05-04 | MILLER RICHARD A MD | President and CEO | 35,714 0.0833% | $2.80 | $99,999 | -13.38% | ||
| 2021-02-17 | Thompson Peter A. | 1.29M 3.6216% | $3.50 | $4.5M | -23.75% |
Insider Historical Profitability
| MILLER RICHARD A MD | President and CEO | 577634 3.0387% | $1.79 | 29 | 0 | +5.51% |
| Jones William Benton | See Remarks | 153773 0.2728% | $1.79 | 2 | 0 | +85.9% |
| Thompson Peter A. | 6943654 14.1596% | $1.79 | 19 | 1 | +4.76% | |
| ORBIMED ADVISORS LLC | 6943654 14.1596% | $1.79 | 19 | 1 | +4.76% | |
| Novo Holdings A/S | 10 percent owner | 1389498 2.8335% | $1.79 | 3 | 5 | +12.06% |
| Gould Terry P | 236128 0.4815% | $1.79 | 2 | 0 | <0.0001% | |
| ADAMS STREET PARTNERS LLC | 10 percent owner | 236128 0.4815% | $1.79 | 2 | 0 | <0.0001% |
| LEA LEIV | Chief Financial Officer | 133238 0.2717% | $1.79 | 6 | 0 | +20.55% |
| EcoR1 Capital, LLC | 10 percent owner | 81077 0.1653% | $1.79 | 0 | 2 | |
| Grais Linda | director | 10000 0.0204% | $1.79 | 1 | 0 | <0.0001% |
Institutional Investor Ownership
| OrbiMed | $12.36M | 11.1 | 6.94M | 0% | +$0 | 0.25 | |
| Adams Street Partners Llc | $5.83M | 5.24 | 3.28M | 0% | +$0 | 2.32 | |
| Samlyn Capital, LLC | $4.18M | 3.75 | 2.35M | -5.92% | -$263,254.87 | 0.07 | |
| The Vanguard Group | $2.66M | 2.39 | 1.49M | +10.57% | +$254,048.68 | <0.0001 | |
| Renaissance Technologies | $1.13M | 1.02 | 637,032 | +8.44% | +$88,294.47 | <0.01 | |
| BlackRock | $930,901.00 | 0.84 | 522,978 | +0.47% | +$4,320.06 | <0.0001 | |
| Towerview LLC | $680,850.00 | 0.61 | 382,500 | -12.45% | -$96,783.94 | 0.5 | |
| Geode Capital Management | $661,894.00 | 0.59 | 371,763 | +3.16% | +$20,266.51 | <0.0001 | |
| Bvf Inc Il | $643,303.00 | 0.58 | 361,406 | -73.64% | -$1.8M | 0.01 | |
| Morgan Stanley | $490,143.00 | 0.44 | 275,361 | +6.05% | +$27,956.70 | <0.0001 | |
| Bridgeway Capital Management | $399,254.00 | 0.36 | 224,300 | +50.23% | +$133,500.00 | 0.01 | |
| Two Sigma Advisers LP | $329,478.00 | 0.3 | 185,100 | -21.43% | -$89,890.00 | <0.01 | |
| State Street | $214,139.00 | 0.19 | 120,303 | -13.08% | -$32,217.95 | <0.0001 | |
| Susquehanna International Group | $186,946.00 | 0.17 | 105,026 | -52.33% | -$205,180.29 | <0.0001 | |
| Two Sigma | $182,359.00 | 0.16 | 102,449 | -43.31% | -$139,293.73 | <0.0001 | |
| Connor Clark & Lunn Investment Management Ltd | $156,654.00 | 0.14 | 88,008 | +23.59% | +$29,903.95 | <0.0001 | |
| Northern Trust | $115,609.00 | 0.1 | 64,949 | -0.1% | -$121.04 | <0.0001 | |
| Jackson Square Capital Llc | $113,516.00 | 0.1 | 63,773 | New | +$113,516.00 | 0.03 | |
| JPMorgan Chase | $94,027.00 | 0.08 | 52,824 | +7,679.68% | +$92,818.38 | <0.0001 | |
| Hikari Power Ltd | $89,000.00 | 0.08 | 49,959 | 0% | +$0 | 0.01 | |
| Millennium Management LLC | $41,440.00 | 0.04 | 23,281 | -42.99% | -$31,245.98 | <0.0001 | |
| Quinn Opportunity Partners Llc | $39,742.00 | 0.04 | 22,327 | New | +$39,742.00 | 0.01 | |
| Commerce Bank | $35,600.00 | 0.03 | 20,000 | 0% | +$0 | <0.0001 | |
| American Century Investments | $32,481.00 | 0.03 | 18,248 | -1.16% | -$380.92 | <0.0001 | |
| Resources Investment Advisors Inc | $31,951.00 | 0.03 | 17,950 | +44.76% | +$9,879.00 | <0.0001 | |
| Charles Schwab | $27,889.00 | 0.03 | 15,668 | 0% | +$0 | <0.0001 | |
| Virtu Financial Llc | $22,000.00 | 0.02 | 12,570 | New | +$22,000.00 | <0.01 | |
| Dimensional Fund Advisors | $21,225.00 | 0.02 | 11,924 | 0% | +$0 | <0.0001 | |
| Fortem Financial Group Llc | $19,580.00 | 0.02 | 11,000 | New | +$19,580.00 | 0.01 | |
| Whittier Trust Co Of Nevada Inc | $19,824.00 | 0.02 | 11,200 | 0% | +$0 | <0.01 | |
| Gillespie Robinson Grimm Inc | $20,434.00 | 0.02 | 11,480 | 0% | +$0 | <0.01 | |
| Tower Research Capital | $20,489.00 | 0.02 | 11,511 | +35.38% | +$5,354.09 | <0.0001 | |
| Masso - Torrence Wealth Management | 401K Plan Consulting | $17,800.00 | 0.02 | 10,000 | 0% | +$0 | 0.01 | |
| Simplex Trading Llc | $16,000.00 | 0.02 | 9,346 | -81.17% | -$68,966.40 | <0.0001 | |
| UBS | $8,329.00 | 0.01 | 4,679 | -30.16% | -$3,597.54 | <0.0001 | |
| Group One Trading | $8,195.00 | 0.01 | 4,604 | -87.44% | -$57,065.96 | <0.0001 | |
| Northwest Capital Management, Inc. | $6,047.00 | 0.01 | 3,397 | 0% | +$0 | <0.01 | |
| Qube Research & Technologies | $4,233.00 | <0.01 | 2,378 | New | +$4,233.00 | <0.0001 | |
| Advisor Group Holdings Inc | $2,136.00 | <0.01 | 1,200 | 0% | +$0 | <0.0001 | |
| RhumbLine Advisers | $1,407.00 | <0.01 | 791 | 0% | +$0 | <0.0001 | |
| Ica Group Wealth Management Llc | $294.00 | <0.01 | 165 | New | +$294.00 | <0.0001 | |
| Parallel Advisors, LLC | $36.00 | <0.01 | 20 | 0% | +$0 | <0.0001 | |
| Barclays | $0 | <0.01 | 1 | 0% | +$0 | <0.0001 | |
| Wells Fargo | $472.00 | <0.01 | 265 | +1.92% | +$8.91 | <0.0001 | |
| Fidelity Investments | $30.00 | <0.01 | 17 | New | +$30.00 | <0.0001 |